We are live on ! Find out more
EHC icon

Encompass Health

604 hedge funds and large institutions have $11.9B invested in Encompass Health in 2025 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 239 increasing their positions, 230 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $9.02M | Put options by funds: $6.93M

10% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 50

4% more repeat investments, than reductions

Existing positions increased: 239 | Existing positions reduced: 230

2% more capital invested

Capital invested by funds: $11.6B → $11.9B (+$261M)

0% less funds holding

Funds holding: 607604 (-3)

1.14% less ownership

Funds ownership: 94.16%93.01% (-1.1%)

50% less funds holding in top 10

Funds holding in top 10: 84 (-4)

Holders
604
Holders Change
-3
Holders Change %
-0.49%
% of All Funds
7.93%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
55
Increased
239
Reduced
230
Closed
50
Calls
$9.02M
Puts
$6.93M
Net Calls
+$2.08M
Net Calls Change
-$8.85M
Name Holding Trade Value Shares
Change
Change in
Stake
HIS
301
Harvest Investment Services
Illinois
$1.18M +$486K +4,080 +79%
DekaBank Deutsche Girozentrale
302
DekaBank Deutsche Girozentrale
Germany
$1.16M
Bessemer Group
303
Bessemer Group
New Jersey
$1.15M -$64K -538 -6%
Federated Hermes
304
Federated Hermes
Pennsylvania
$1.14M -$49K -412 -4%
QCM
305
Qsemble Capital Management
New York
$1.14M -$45K -378 -4%
QCG
306
Quadrant Capital Group
Ohio
$1.12M -$3.93K -33 -0.4%
FLA
307
Financial Life Advisors
Texas
$1.11M +$1.55K +13 +0.1%
STA
308
Summit Trail Advisors
New York
$1.1M +$674K +5,665 +187%
ET
309
Entropy Technologies
New York
$1.07M -$434K -3,643 -30%
CGH
310
Crossmark Global Holdings
Texas
$1.06M -$90.5K -760 -8%
OSAM
311
O'Shaughnessy Asset Management
Connecticut
$1.06M +$262K +2,202 +36%
CAPTRUST Financial Advisors
312
CAPTRUST Financial Advisors
North Carolina
$1.05M +$213K +1,786 +27%
TPCW
313
TD Private Client Wealth
New York
$1.04M +$10.8K +91 +1%
IG
314
ING Group
Netherlands
$1.04M +$976K +8,200 New
Mariner
315
Mariner
Kansas
$1.03M +$360K +3,022 +59%
QCM
316
QRG Capital Management
Illinois
$1.02M -$1.16M -9,772 -55%
FRM
317
Fox Run Management
Connecticut
$1.02M -$304K -2,552 -24%
BEI
318
Benjamin Edwards Inc
Missouri
$1M +$329K +2,767 +54%
NI
319
Natural Investments
California
$991K +$10.6K +89 +1%
US Bancorp
320
US Bancorp
Minnesota
$990K +$6.91K +58 +0.7%
OQS
321
Occudo Quantitative Strategies
Florida
$987K +$603K +5,068 +188%
Cambridge Investment Research Advisors
322
Cambridge Investment Research Advisors
Iowa
$984K -$194K -1,628 -17%
LWAM
323
Legacy Wealth Asset Management
Minnesota
$980K +$23K +193 +3%
UCFA
324
United Capital Financial Advisors
Texas
$978K +$707K +5,940 +338%
GCP
325
GSA Capital Partners
United Kingdom
$975K -$348K -2,923 -28%

EHC Hedge Fund Activity: Q3 2025 in Review

604 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q3 2025, worth a combined $11.9B — up 2.2% from $11.6B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new EHC positions and 50 closed out — a net gain of 5 holders — while 239 added to existing stakes and 230 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $292M. The largest seller was Wellington Management Group, cutting an estimated $88.6M.

  • 604 institutional investors held Encompass Health (EHC) as of Q3 2025, down from 607 in Q2 2025.
  • Funds reported $11.9B of Encompass Health stock for Q3 2025, up 2.2% quarter-over-quarter.
  • 55 funds opened new Encompass Health positions in Q3 2025 and 50 closed out, a net change of +5 holders.
  • The largest Encompass Health buyer in Q3 2025 was T. Rowe Price Associates, an estimated $292M added.
  • The largest Encompass Health seller in Q3 2025 was Wellington Management Group, an estimated $88.6M sold.

Based on aggregated 13F filings for Q3 2025.